Hi, mooers!
Welcome back to Maple Market Challenge!  
Like always, let's reveal the answer to last week's quiz: At what price per share is Scotiabank acquiring the stake in KeyCorp? The answer is $17.17.
A big round of applause to those who got it right! Each of you will receive 20 points. Plus, we're giving 50 points to everyone who left a comment. Well done, everyone! A private message with...

$Cassava Sciences (SAVA.US)$Insiders never sold when it went to $147. Now we are finishing Phase 3 and FDA just approved extension with 89% asking to stay on safe , effective drug for treating AD.  This is worth  way more than current price.  The only oral pill treatment that actually slows cognitive decline and improves cognition.  Breakthrough SAVA.

$Cassava Sciences (SAVA.US)$For 3.5 years, shorts manipulated the stock price  with fake shares and FUD.  HF & Shorts cheated and got greedy. They should have covered  a long time ago but  their greed is going to backfire as 17Million shares short . FDA  approved extension and 89% of people requested to stay on drug extension on  AD debilitating disease that is safe, effective and best treatment.  These phantom shares are also being recorded and news will come out about that too.

$Cassava Sciences (SAVA.US)$Why would people choose to stay on simufilan on extended trial if the drug didn’t work on a debilitating disease such as AD? AD gets violently worse over time . There’s never been an issue of safety and patient families and doctors testimony that sava works. 1900 people on this are not going to want to get off the drug and get worse again.  The drug works

$Rivian Automotive (RIVN.US)$ tanking! Can it go any lower?

What are you doing with your $NIO Inc (NIO.US)$ $XPeng (XPEV.US)$ $Li Auto (LI.US)$ position today!?